| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |